Jane Street’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Jane Street’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-370,827	Closed	-$3.8M	–	10005
2023 Q1	$3.8M	Sell	370,827 -140	-0%	-$1.42K	﹤0.01%	2815
2022 Q4	$3.73M	Buy	+370,967	New	+$3.69M	﹤0.01%	2900

Jane Street's ORIA Position: Q2 2023 in Review

Jane Street sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 370,827 shares — an estimated $3.8M sold.

Jane Street first reported a position in ORIA in Q4 2022 and held it in 2 quarters. The position peaked at $3.8M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Jane Street reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Jane Street sold 370,827 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $3.8M.
Jane Street first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2022 and held it in 2 quarters.
Jane Street's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $3.8M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.